Detection of cervical antibodies to human papillomavirus type 16 (HPV- 16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions

Journal of Infectious Diseases

Volumn 181, Issue 4, 2000, Pages 1234-1239

  Hagensee, Michael E ^a,b   Koutsky, Laura A ^a   Lee, Shu Kuang ^a   Grubert, Thomas ^a,c   Kuypers, Jane ^a   Kiviat, Nancy B ^a   Galloway, Denise A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIGEN; VIRUS DNA;

ADULT; ANTIBODY DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOASSAY; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX EPITHELIUM; VIRUS CAPSID; WART VIRUS;

ADULT; ANTIBODIES, VIRAL; CAPSID; CERVIX UTERI; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN A, SECRETORY; LUMINESCENT MEASUREMENTS; PAPILLOMAVIRIDAE;

EID: 0034062375     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315364     Document Type: Article

References (35)

1. 1. Koutsky LA, Galloway DA, Holmes KK. The epidemiology of genital papillomavirus infections. Epidemiol Rev 1988; 10:122-63.
2. 2. zur Hausen H. Viruses in human cancers. Science 1991; 254:1167-73.
3. 3. Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnurch HG, zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 1983; 80:560-3.
4. 4. Hagensee ME, Yaegashi N, Galloway DA. Self-assembly of human papiliomavirus type I capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol 1993; 67:315-22.
5. 5. Kirnbauer R, Taub J, Greenstone H, et al. Efficient self-assembly of human papillomavirus type-16 L1 and L1-L2 into virus-like particles. J Virol 1993; 67:6929-36.
6. 6. Rose RC, Bonnez W, Reichman RC, Garcea RL. Expression of human papillomavirus type 11 L1 protein in insect cells: in vitro assembly of viruslike particles. J Virol 1993; 67:1936-44.
7. 7. Zhou J, Sun XY, Stenzel DJ, Frazer IH. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 1991; 185:251-7.
8. 8. Hofmann KJ, Cook JC, Joyce JG, et al. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology 1995; 209:506-18.
9. 9. Hagensee ME, Olson NH, Baker TS, Galloway DA. Three-dimensional structure of vaccinia virus-produced HPV-1 capsids. J Virol 1994; 68:4503-5.
10. 10. Carter JJ, Wipf GC, Hagensee ME, et al. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. J Infect Dis 1995; 172:11-8.
11. 11. Carter JJ, Koutsky LA, Wipf GC, et al. The natural history of HPV-16 capsid antibodies among a cohort of university women. J Infect Dis 1996; 174: 927-36.
12. 12. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994; 86:494-9.
13. 13. Nonnenmacher B, Hubbert NL, Kirnbauer R, et al. Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J Infect Dis 1995; 172:19-24.
14. 14. Le Cann P, Touze A, Enogat N, et al. Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus. J Clin Microbiol 1995; 33:1380-2.
15. 15. Rose RC, Reichman RC, Bonnez W. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J Gen Virol 1994; 75:2075-9.
16. 16. Wideroff L, Schiffman MH, Nonnenmacher B, et al. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis 1995; 172: 1425-30.
17. 17. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 1987; 7:265-76.
18. 18. McGhee JR, Mestecky J, Derzbaugh MT, Eldridge JH, Jirasawa M, Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992; 10:75-88.
19. 19. Kutteh WH, Hatch KD, Blackwell RE, Mestecky J. Secretory immune system of the female reproductive tract. I. Immunoglobulin and secretory component containing cells. Obstet Gynecol 1988; 71:56-60.
20. 20. Kutteh WH, Kutteh CC, Blackwell RE, Carr BR, Gore H, Mestecky J. Secretory immune system of the female reproductive tract. II. Local immune system in normal and infected fallopian tube. Fertil Steril 1990; 54: 51-5.
21. 21. Dillner J, Dillner L, Robb J, et al. A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proc Natl Acad Sci USA 1989; 86:3838-41.
22. 22. Dillner L, Dekassy Z, Jonsson N, Moreno-Lopez J, Blomberg J. Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia. Int J Cancer 1989; 43:36-40.
23. 23. Dillner L, Fredriksson A, Persson E, Forslund O, Hansson B, Dillner J. Antibodies against papillomavirus antigens in cervical secretions from condyloma patients. J Clin Microbiol 1993; 31:192-7.
24. 24. Wang Z, Hansson B, Forslund O, et al. Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA. J Clin Microbiol 1996; 34:3056-62.
25. 25. Ashley RL, Corey L, Dalessio J, et al. Protein-specific cervical antibody responses to primary genital herpes simplex virus type 2 infections. J Infect Dis 1994; 170:20-6.
26. 26. Quesnel A, Cu-Uvin S, Murphy D, Ashley RL, Flanigan T, Neutra NK. Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women. J Immunol Methods 1997; 202:153-61.
27. 27. Kiviat NB, Critchlow CW, Holmes KK, et al. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. AIDS 1993; 7:43-9.
28. 28. The Bethesda system for reporting cervical/vaginal cytologic diagnoses NCI workshop [editorial]. JAMA 1989; 262:931-3.
29. 29. Dresner LS, Wang SP, West MW, Ponomarenko IN, Mueller CM, Wait RB. Nitric oxide inhibition simulates the enhancement of a-1 agonist-induced vasoconstriction in diabetes. J Surg Res 1997; 70:119-23.
30. 30. Brunham RC, Kuo C, Cles L, Holmes KK. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun 1983; 39:1491-4.
31. 31. Merriman H, Woods S, Winter C, Fahnlander A, Corey L. Secretory IgA antibody in cervicovaginal secretions from women with genital infection due to herpes simplex virus. J Infect Dis 1984; 149:505-10.
32. 32. Molyneaux PJ. Human immunity to rotavirus. J Med Microbiol 1995; 43: 397-404.
33. 33. Crowley-Nowick PA, Bell M, Edwards RP, et al. Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretion. Am J Reprod Immunol 1995; 34:241-7.
34. 34. Critchlow CW, Holmes KK, Wood R, et al. Association of human immunodeficiency virus and anal human papillomavirus infection among homosexual men. Arch Intern Med 1992; 152:1673-6.
35. 35. Halpert R, Butt K, Fruchter RG, Boyce JG, Sedlis A, Sillman FH. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986; 68:251-8.